IL6 and melanoma: This effect was not restricted to the B16 melanoma line, since culture supernatant or cell lysates from Mycoplasma-contaminated CT26 colon carcinoma cells or the EL4 lymphoma cell line also resulted in potent IL-6 release from co-cultured bone marrow cells (S1 Fig).